Pharmaceuticals, Biotechnology and Life Sciences
A correction from source is being issued with respect to the press release titled, Firefly Neuroscience Achieves Multi-Fold Database, IP…
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 05, 2025 (GLOBE…
HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the…
Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia…
In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp…
Novel Endoscopic Procedure Demonstrates Substantial and Durable Reduction in Insulin Resistance and Improvement in Beta Cell Function for People with…
Company Announcement Decision to submit based on a positive overall response rate (ORR) (p-value < 0.0001), one of the dual…
REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that the company will…
FREEHOLD, N.J., May 01, 2025 (GLOBE NEWSWIRE) — Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer…
OBI-902 is the first ADC utilizing OBI’s proprietary GlycOBI® ADC enabling technologyTAIPEI, Taiwan, May 01, 2025 (GLOBE NEWSWIRE) — OBI…